OQS
KYNB

Occudo Quantitative Strategies’s Kyntra Bio KYNB Stock Holding History

Occudo Quantitative Strategies’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,562
Closed -$91.8K – 823
2024
Q1 		$91.8K Sell
1,562
-1,271
-45% -$54.8K 0.02% 658
2023
Q4 		$62.8K Hold
2,833
– – 0.01% 733
2023
Q3 		$61.1K Hold
2,833
– – 0.01% 907
2023
Q2 		$191K Buy
2,833
+1,527
+117% +$632K 0.02% 856
2023
Q1 		$609K Buy
+1,306
New +$691K 0.06% 457
2022
Q4 		– Sell
-2,774
Closed -$902K – 1105
2022
Q3 		$902K Buy
+2,774
New +$893K 0.07% 444
2021
Q4 		– Sell
-1,292
Closed -$330K – 1121
2021
Q3 		$330K Buy
+1,292
New +$458K 0.04% 696

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Occudo Quantitative Strategies's KYNB Position: Q2 2024 in Review

Occudo Quantitative Strategies sold out of Kyntra Bio (KYNB) in Q2 2024, closing a stake of 1,562 shares — an estimated $91.8K sold.

Occudo Quantitative Strategies first reported a position in KYNB in Q3 2021 and held it in 7 quarters. The position peaked at $902K in Q3 2022. 102 funds tracked by Wall St. Rank hold KYNB as of Q2 2024.

  • Occudo Quantitative Strategies reported no remaining Kyntra Bio position as of Q2 2024 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 1,562 Kyntra Bio shares in Q2 2024, an estimated $91.8K.
  • Occudo Quantitative Strategies first reported a position in Kyntra Bio in Q3 2021 and held it in 7 quarters.
  • Occudo Quantitative Strategies's Kyntra Bio position peaked at $902K in Q3 2022.
  • 102 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2024.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.